• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Strolll: Venture Capital Funding History

Strolll

To add a bio or update company history, please click update information.

News from Strolll

    Strolll secures £4.3m in funding from Innovate UK and IW Capital for augmented reality neurorehabilitationStrolll secures £4.3m in funding from Innovate UK and IW Capital for augmented reality neurorehabilitation
    Strolll
    3 Sept 2026

    Strolll secures £4.3m in funding from Innovate UK and IW Capital for augmented reality neurorehabilitation

    Strolll is a software as a medical device company that delivers neurorehabilitation through off-the-shelf augmented reality glasses. The clinically proven and patented platform blends digital content with the real world, allowing neurorehabilitation providers to treat patients living with neurological disorders in both clinic and home settings.

    Strolll raises £10m Series A led by IW Capital to expand AR-based neurorehabilitationStrolll raises £10m Series A led by IW Capital to expand AR-based neurorehabilitation
    Strolll
    11 Mar 2025

    Strolll raises £10m Series A led by IW Capital to expand AR-based neurorehabilitation

    Strolll creates augmented reality therapy using smart glasses and game-based exercises to support people with neurological conditions, enabling clinicians to deliver more intensive physiotherapy with less staff time across clinical and home-based settings.

Strolll
  • Health
  • Stafford, United Kingdom
  • £14.3m
  • strolll.co
  • Update Information

More venture news

  • Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
    Inovus Medical
    30 Sept 2026

    Inovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training

    EquityHealth
  • DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records
    DYAD
    29 Sept 2026

    DYAD secures a £7.5m Series A led by Sangha Capital for its system that converts clinical documents into structured data for GP patient records

    Series AHealth
  • IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS
    IMS Solutions
    24 Sept 2026

    IMS Solutions raises a £1.1m seed round led by Midlands Mindforge to develop steroid tests for cancer and PMOS

    SeedHealth

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn